Press Releases

Camber Pharmaceuticals is thrilled to announce the addition of Aripiprazole Oral Solution to its product line, complementing the existing product family that included Aripiprazole Tablets.

The partnership aims to accelerate innovation in drug discovery by increasing success rates and reducing timelines through screening a billion+ small-molecule compounds either in a living cell or on a purified drug target protein.

In September 2022, Bayer launched the patented drug vericiguat under the brand name Verquvo™ in India.

Camber Pharmaceuticals is pleased to announce the addition of Levonorgestrel and Ethinyl Estradiol Tablets USP to its current portfolio.

Aurigene.AI is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene's core expertise in synthesizing and testing the molecules in vitro and in vivo.

Camber Pharmaceuticals is pleased to announce the addition of Allopurinol Tablets, USP to its current portfolio.

Alabama Pharmacist Recognized for Advancing the Profession of Pharmacy

Theophylline Extended-Release Tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases.

Versavo® (bevacizumab) is indicated for the treatment of several types of cancers including metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, advanced cervical cancer, ovarian cancer and metastatic breast cancer.

Gabapentin Tablets (generic for Gralise®) are indicated for the management of Postherpetic Neuralgia (PHN).

Registration open for McKesson ideaShare, premier community pharmacy education and networking event

Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.

NCPA members highlighted during White House roundtable on PBMs and virtual town hall on monopoly power.

The National Community Pharmacists Association issued a statement on behalf of CEO B. Douglas Hoey.

Oxcarbazepine Oral Suspension, USP 300 mg/5 mL is available in 250 mL bottles.

Point-of-care testing services enhance patient care, support pharmacy revenue

This annual award, overseen by NASPA and sponsored by Upsher-Smith, acknowledges innovative pharmacists from across the nation for their outstanding contributions to the field of pharmacy.

Camber Pharmaceuticals is pleased to announce the addition of Paliperidone Extended-Release Tablets to its current portfolio.

The National Community Pharmacists Association is pleased to announce that it has named Mark Ey, RPh, as its new chief operating officer.

Quality Products, Innovative Technology, and Exceptional Customer Service Characterize a Successful Inaugural Year

The podcast aims to explore and discuss various pharmacy-related topics with insights from industry experts, highlighting the transformative role of technology in today's evolving pharmacy landscape.

Dr. Reddy’s acquired the entire MenoLabs supplements portfolio which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause.

Company also secures 'Gold Medal' status from global sustainability ratings agency, EcoVadis

Under the Agreement, Dr. Reddy’s will obtain commercialization rights for COYA 302 in the United States, Canada, the European Union and the United Kingdom, for patients with ALS.

Camber Pharmaceuticals is pleased to announce the addition of Famotidine Powder for Oral Suspension, USP to its current portfolio.